California encephalitis virus: Difference between revisions
m (Changes made per Mahshid's request) |
|||
(20 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
{{CMG}} {{AE}} {{AG}} | {{CMG}} {{AE}} {{AG}} | ||
{{SK}} CEV; CVE; California virus encephalitis; | {{SK}} CEV; CVE; California virus encephalitis; CE virus | ||
{{see also|La Crosse encephalitis}} | |||
==Overview== | ==Overview== | ||
California encephalitis virus is a mild infection of the [[central nervous system]]. California encephalitis virus belongs to the Group V [[negative-sense ssRNA virus]] within the [[Bunyaviridae]] family of viruses. It is also known as an [[arbovirus]]. California encephalitis virus is usually transmitted via [[mosquito]]s to the human host.<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref> California encephalitis virus contains [[negative-sense ssRNA virus|negative-sense]] viral [[RNA]]; this RNA is [[complementary]] to [[mRNA]] and thus must be converted to [[positive-sense RNA]] by an [[RNA polymerase]] before [[translation]]. California encephalitis virus is contracted by the [[bite]] of an infected [[mosquito]], primarily Aedes triseriatus. California encephalitis virus must be differentiated from other diseases that cause [[fever]], [[headache]], [[seizures]], and [[altered mental status]]. There are approximately 70-115 cases of California encephalitis virus per year in the United States, most commonly affecting infants and children between the ages of 6 months and 15 years old. California encephalitis virus usually clears in 1 to 2 weeks and rarely recurs. Less than 1% of cases result in [[mortality]].<ref name=OHIOPubHealth> La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.</ref> However, approximately 20% of patients have residual [[seizure]]s. The diagnostic method of choice for California encephalitis virus is laboratory testing. There is no treatment for California encephalitis virus; the mainstay of therapy is supportive care.<ref name=IDSAEnceph> The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America. http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Encephalitis.pdf Accessed on February 16, 2016.</ref> | California encephalitis virus is a mild infection of the [[central nervous system]]. California encephalitis virus belongs to the Group V [[negative-sense ssRNA virus]] within the [[Bunyaviridae]] family of viruses. It is also known as an [[arbovirus]]. California encephalitis virus is usually transmitted via [[mosquito]]s to the human host.<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref> California encephalitis virus contains [[negative-sense ssRNA virus|negative-sense]] viral [[RNA]]; this RNA is [[complementary]] to [[mRNA]] and thus must be converted to [[positive-sense RNA]] by an [[RNA polymerase]] before [[translation]]. California encephalitis virus is contracted by the [[bite]] of an infected [[mosquito]], primarily Aedes triseriatus. California encephalitis virus must be differentiated from other diseases that cause [[fever]], [[headache]], [[seizures]], and [[altered mental status]]. There are approximately 70-115 cases of California encephalitis virus per year in the United States, most commonly affecting infants and children between the ages of 6 months and 15 years old. California encephalitis virus usually clears in 1 to 2 weeks and rarely recurs. Less than 1% of cases result in [[mortality]].<ref name=OHIOPubHealth> La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.</ref> However, approximately 20% of patients have [[residual]] [[seizure]]s. The diagnostic method of choice for California encephalitis virus is laboratory testing. There is no treatment for California encephalitis virus; the mainstay of therapy is supportive care.<ref name=IDSAEnceph> The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America. http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Encephalitis.pdf Accessed on February 16, 2016.</ref> | ||
==Historical Perspective== | ==Historical Perspective== | ||
Line 11: | Line 13: | ||
==Classification== | ==Classification== | ||
There is no classification system established for California encephalitis virus. California encephalitis virus belongs to the Group V [[negative-sense ssRNA virus]] within the [[Bunyaviridae]] family of viruses, and the genus [[Orthobunyavirus]]. California encephalitis virus is also known as an [[arbovirus]], or an arthropod-borne virus.<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref> The California encephalitis [[serotype|serogroup]], which contains genetically similar viruses such as [[La Crosse encephalitis]], shares its name with the virus. | There is no classification system established for California encephalitis virus. California encephalitis virus belongs to the Group V [[negative-sense ssRNA virus]] within the [[Bunyaviridae]] family of viruses, and the genus [[Orthobunyavirus]]. California encephalitis virus is also known as an [[arbovirus]], or an arthropod-borne virus.<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref> The California encephalitis [[serotype|serogroup]], which contains genetically similar viruses such as the [[La Crosse encephalitis|La Crosse virus]], shares its name with the virus. | ||
==Pathophysiology== | ==Pathophysiology== | ||
California encephalitis virus is usually transmitted via [[mosquito]]s to the human host.<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref> California encephalitis virus contains [[negative-sense ssRNA virus|negative-sense]] viral [[RNA]]; this RNA is [[complementary]] to [[mRNA]] and thus must be converted to [[positive-sense RNA]] by an [[RNA polymerase]] before [[translation]]. California encephalitis virus is made up of an [[enveloped virus|enveloped virion]] with a helically symmetrical [[capsid]]. The envelope contains G1 glycoproteins. Neutralizing [[antibodies]] against these proteins block fusion of the virus with host cells and inhibit [[hemagglutination]]. The virus genome is over 12000 [[nucleotide]]s in length and consists of three segments of various sized single-stranded [[RNA]] (negative sense and ambi-sense). | California encephalitis virus is usually transmitted via [[mosquito]]s to the human host.<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref> California encephalitis virus contains [[negative-sense ssRNA virus|negative-sense]] viral [[RNA]]; this RNA is [[complementary]] to [[mRNA]] and thus must be converted to [[positive-sense RNA]] by an [[RNA polymerase]] before [[translation]]. California encephalitis virus is made up of an [[enveloped virus|enveloped virion]] with a helically symmetrical [[capsid]]. The envelope contains G1 glycoproteins. Neutralizing [[antibodies]] against these proteins block fusion of the virus with host cells and inhibit [[hemagglutination]]. The virus genome is over 12000 [[nucleotide]]s in length and consists of three segments of various sized single-stranded [[RNA]] (negative sense and ambi-sense). | ||
California encephalitis virus is contracted by the [[bite]] of an infected [[mosquito]], primarily Aedes triseriatus. The virus is maintained and amplified in Aedes triseriatus populations through [[transovarial transmission|transovarial]] and [[venereal transmission]]. The virus overwinters in the mosquito egg. Amplification also occurs in chipmunks and squirrels, upon which | California encephalitis virus is contracted by the [[bite]] of an infected [[mosquito]], primarily Aedes triseriatus. The virus is maintained and amplified in Aedes triseriatus populations through [[transovarial transmission|transovarial]] and [[venereal|venereal transmission]]. The virus overwinters in the mosquito egg. [[Amplification]] also occurs in chipmunks and squirrels, upon which mosquitos feed. Humans are dead-end hosts for the virus, meaning there is an insufficient amount of California encephalitis virus in the blood stream to infect a mosquito. Subsequently, the disease cannot be spread to other humans. The [[incubation period]] is 5-15 days.<ref name=OHIOPubHealth> La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.</ref> | ||
==Causes== | ==Causes== | ||
Line 22: | Line 24: | ||
==Differentiating California Encephalitis Virus from other Diseases== | ==Differentiating California Encephalitis Virus from other Diseases== | ||
California encephalitis virus must be differentiated from other diseases that cause [[fever]], [[headache]], [[seizures]], and [[altered mental status]], such as:<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref><ref name="pmid14978145">{{cite journal| author=Kennedy PG| title=Viral encephalitis: causes, differential diagnosis, and management. | journal=J Neurol Neurosurg Psychiatry | year= 2004 | volume= 75 Suppl 1 | issue= | pages= i10-5 | pmid=14978145 | doi= | pmc=PMC1765650 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14978145 }} </ref><ref name=NYDeptofHealth> Arboviral Infections (arthropod-borne encephalitis, eastern equine encephalitis, St. Louis encephalitis, California encephalitis, Powassan encephalitis, West Nile encephalitis). New York State Department of Health (2006). https://www.health.ny.gov/diseases/communicable/arboviral/fact_sheet.htm Accessed on February 23, 2016 </ref> | California encephalitis virus must be differentiated from other diseases that cause [[fever]], [[headache]], [[seizures]], and [[altered mental status]], such as:<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref><ref name="pmid14978145">{{cite journal| author=Kennedy PG| title=Viral encephalitis: causes, differential diagnosis, and management. | journal=J Neurol Neurosurg Psychiatry | year= 2004 | volume= 75 Suppl 1 | issue= | pages= i10-5 | pmid=14978145 | doi= | pmc=PMC1765650 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14978145 }} </ref><ref name=NYDeptofHealth> Arboviral Infections (arthropod-borne encephalitis, eastern equine encephalitis, St. Louis encephalitis, California encephalitis, Powassan encephalitis, West Nile encephalitis). New York State Department of Health (2006). https://www.health.ny.gov/diseases/communicable/arboviral/fact_sheet.htm Accessed on February 23, 2016 </ref><ref name="pmid21932127">{{cite journal| author=Eckstein C, Saidha S, Levy M| title=A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. | journal=J Neurol | year= 2012 | volume= 259 | issue= 5 | pages= 801-16 | pmid=21932127 | doi=10.1007/s00415-011-6240-5 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21932127 }} </ref><ref name="pmid11260760">{{cite journal| author=De Kruijk JR, Twijnstra A, Leffers P| title=Diagnostic criteria and differential diagnosis of mild traumatic brain injury. | journal=Brain Inj | year= 2001 | volume= 15 | issue= 2 | pages= 99-106 | pmid=11260760 | doi=10.1080/026990501458335 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11260760 }} </ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align=center | ||
|+ | |+ | ||
! style="background: #4479BA; width: | ! style="background: #4479BA; width: 50px;" | {{fontcolor|#FFF|Disease}} | ||
! style="background: #4479BA; width: | ! style="background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Similarities}} | ||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Differentials}} | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[ | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Meningitis]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | Classic triad of [[fever]], [[nuchal rigidity]], and [[altered mental status]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Photophobia]], [[phonophobia]], [[rash]] associated with [[meningococcemia]], concomitant [[sinusitis]] or [[otitis]], swelling of the [[fontanelle]] in infants (0-6 months) | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[ | | style="padding: 5px 5px; background: #DCDCDC;" |'''[[Brain abscess]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | [[Fever]], [[headache]], [[hemiparesis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Varies depending on the location of the abscess; clinically, [[visual disturbance]] including [[papilledema]], decreased [[sensation]]; on imaging, a [[lesion]] demonstrates both ring enhancement and central restricted diffusion | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[ | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Demyelinating disease]]s''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | [[Ataxia]], [[lethargy]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Multiple sclerosis]]: clinically, [[nystagmus]], [[internuclear ophthalmoplegia]], [[Lhermitte's sign]]; on imaging, well-demarcated ovoid lesions with possible T1 hypointensities (“black holes”) | |||
[[Acute disseminated encephalomyelitis]]: clinically, [[somnolence]], [[myoclonic]] movements, and [[hemiparesis]]; on imaging, diffuse or multi-lesion enhancement, with indistinct lesion borders | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[ | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Substance abuse]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | [[Tremor]], [[headache]], [[altered mental status]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Varies depending on type of substance: prior history, drug-seeking behavior, attention-seeking behavior, [[paranoia]], sudden [[panic]], [[anxiety]], [[hallucination]]s | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[ | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Electrolyte disturbance]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | [[Fatigue]], [[headache]], [[nausea]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Varies depending on deficient ions; clinically, [[edema]], [[constipation]], [[hallucination]]s; on [[EKG]], abnormalities in [[T wave]], [[P wave]], [[QRS complex]]; possible presentations include [[arrhythmia]], [[dehydration]], [[renal failure]] | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Stroke]]''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | [[Ataxia]], [[aphasia]], [[dizziness]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Varies depending on classification of stroke; presents with positional [[vertigo]], high [[blood pressure]], [[extremities|extremity]] weakness | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |'''[[ | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Intracranial hemorrhage]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | [[Headache]], [[coma]], [[dizziness]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Lobar [[hemorrhage]], [[numbness]], [[tingling]], [[hypertension]], [[hemorrhagic diathesis]] | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[ | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Trauma]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | [[Headache]], [[altered mental status]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | [[Amnesia]], [[loss of consciousness]], [[dizziness]], [[concussion]], [[contusion]] | |||
|- | |- | ||
|} | |} | ||
Line 54: | Line 69: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
There are approximately 70-115 cases of California encephalitis virus per year in the United States. | There are approximately 70-115 cases of California encephalitis virus per year in the United States. | ||
===Age=== | ===Age=== | ||
California encephalitis virus commonly affects individuals between 6 months old and 15 years of age. | California encephalitis virus commonly affects individuals between 6 months old and 15 years of age. | ||
===Seasonal=== | ===Seasonal=== | ||
The majority of California encephalitis virus cases are reported | The majority of California encephalitis virus cases are reported in the summer months between July and September, and peaks in August. | ||
===Geographic Location=== | ===Geographic Location=== | ||
Line 75: | Line 90: | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
===Natural History=== | ===Natural History=== | ||
California encephalitis virus usually clears in 1 to 2 weeks and rarely recurs | California encephalitis virus usually clears in 1 to 2 weeks and rarely recurs. | ||
===Complications=== | ===Complications=== | ||
Line 85: | Line 100: | ||
===Prognosis=== | ===Prognosis=== | ||
Prognosis for California encephalitis virus is generally good, with most individuals returning to full health in 2-3 weeks. | Prognosis for California encephalitis virus is generally good, with most individuals returning to full health in 2-3 weeks. Less than 1% of cases result in [[mortality]].<ref name=OHIOPubHealth> La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.</ref> However, approximately 20% of patients have [[residual]] [[seizure]]s. | ||
==Diagnosis== | ==Diagnosis== | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
If possible, a detailed and thorough history from the patient is necessary. In rare cases, California encephalitis virus presents with symptoms mimicking [[herpes simplex encephalitis]].<ref name="pmid11744319">{{cite journal| author=Sokol DK, Kleiman MB, Garg BP| title=LaCrosse viral encephalitis mimics herpes simplex viral encephalitis. | journal=Pediatr Neurol | year= 2001 | volume= 25 | issue= 5 | pages= 413-5 | pmid=11744319 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11744319 }} </ref> Common symptoms of California encephalitis virus include:<ref name="pmid26595861">{{cite journal| author=Richie MB, Josephson SA| title=A Practical Approach to Meningitis and Encephalitis. | journal=Semin Neurol | year= 2015 | volume= 35 | issue= 6 | pages= 611-20 | pmid=26595861 | doi=10.1055/s-0035-1564686 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26595861 }} | If possible, a detailed and thorough history from the patient is necessary. In rare cases, California encephalitis virus presents with symptoms mimicking [[herpes simplex encephalitis]].<ref name="pmid11744319">{{cite journal| author=Sokol DK, Kleiman MB, Garg BP| title=LaCrosse viral encephalitis mimics herpes simplex viral encephalitis. | journal=Pediatr Neurol | year= 2001 | volume= 25 | issue= 5 | pages= 413-5 | pmid=11744319 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11744319 }} </ref> Common symptoms of California encephalitis virus include:<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref><ref name="pmid26595861">{{cite journal| author=Richie MB, Josephson SA| title=A Practical Approach to Meningitis and Encephalitis. | journal=Semin Neurol | year= 2015 | volume= 35 | issue= 6 | pages= 611-20 | pmid=26595861 | doi=10.1055/s-0035-1564686 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26595861 }} </ref> | ||
*[[Fever]] | *[[Fever]] | ||
*[[Headache]] | *[[Headache]] | ||
Line 108: | Line 123: | ||
*Acute flaccid [[myelitis]] | *Acute flaccid [[myelitis]] | ||
*Acute flaccid [[paralysis]] | *Acute flaccid [[paralysis]] | ||
[[Image:Bunyaviridae02.jpeg|thumb|This negatively-stained transmission electron micrograph ([[TEM]]) revealed the presence of numerous California encephalitis virus virions. Contained within its enveloped capsid, the genome of this [[Bunyaviridae]] family member consists of three segments of [[negative-sense]] single-stranded RNA ((-)ssRNA). <SMALL><SMALL>''[http://phil.cdc.gov/phil/home.asp From Public Health Image Library (PHIL).] ''<ref name=PHIL> {{Cite web | title = Public Health Image Library (PHIL) | url = http://phil.cdc.gov/phil/home.asp}}</ref></SMALL></SMALL>|200px|right]] | |||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
The diagnostic method of choice for California encephalitis virus is laboratory testing. Laboratory findings consistent with the diagnosis of California encephalitis virus include:<ref name=OHIOPubHealth> La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.</ref> | The diagnostic method of choice for California encephalitis virus is laboratory testing. Laboratory findings consistent with the diagnosis of California encephalitis virus include:<ref name=OHIOPubHealth> La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.</ref> | ||
*[[Serologic]] [[cross-reactivity]] | *[[Serologic]] [[cross-reactivity]] | ||
*Presence [[IgM]] [[antibody|antibodies]] | *Presence of [[IgM]] [[antibody|antibodies]] | ||
*Persistence of [[IgG]] and neutralizing [[antibody|antibodies]] | *Persistence of [[IgG]] and neutralizing [[antibody|antibodies]] | ||
*Confirmation of arboviral-specific neutralizing antibodies in [[ | *Confirmation of arboviral-specific neutralizing antibodies in [[enzyme linked immunosorbent assay (ELISA)]] | ||
===EEG=== | ===EEG=== | ||
On [[EEG]], California encephalitis virus | On [[EEG]], California encephalitis virus is characterized by periodic lateralizing epilepitoform discharges.<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref> However, results on imaging are not sufficient evidence to warrant California encephalitis virus diagnosis. | ||
==Treatment== | ==Treatment== | ||
Line 124: | Line 141: | ||
===Surgery=== | ===Surgery=== | ||
Surgical intervention is not recommended for the management of California encephalitis virus. | Surgical intervention is not recommended for the management of California encephalitis virus.<ref name=Mandell1> M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.</ref> | ||
===Prevention=== | ===Prevention=== | ||
There are no available vaccines against California encephalitis virus. Primary prevention strategies include:<ref name=OHIOPubHealth> La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.</ref> | There are no available vaccines against California encephalitis virus. Primary prevention strategies include:<ref name=OHIOPubHealth> La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.</ref> | ||
*Removal of standing water | *Removal of [[standing water]] | ||
*Screens on doors and windows | *Screens on doors and windows | ||
*When outdoors, wearing: | *When outdoors, wearing: | ||
Line 137: | Line 153: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Viruses]] | [[Category:Viruses]] | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} |
Latest revision as of 17:18, 18 September 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anthony Gallo, B.S. [2]
Synonyms and keywords: CEV; CVE; California virus encephalitis; CE virus
Overview
California encephalitis virus is a mild infection of the central nervous system. California encephalitis virus belongs to the Group V negative-sense ssRNA virus within the Bunyaviridae family of viruses. It is also known as an arbovirus. California encephalitis virus is usually transmitted via mosquitos to the human host.[1] California encephalitis virus contains negative-sense viral RNA; this RNA is complementary to mRNA and thus must be converted to positive-sense RNA by an RNA polymerase before translation. California encephalitis virus is contracted by the bite of an infected mosquito, primarily Aedes triseriatus. California encephalitis virus must be differentiated from other diseases that cause fever, headache, seizures, and altered mental status. There are approximately 70-115 cases of California encephalitis virus per year in the United States, most commonly affecting infants and children between the ages of 6 months and 15 years old. California encephalitis virus usually clears in 1 to 2 weeks and rarely recurs. Less than 1% of cases result in mortality.[2] However, approximately 20% of patients have residual seizures. The diagnostic method of choice for California encephalitis virus is laboratory testing. There is no treatment for California encephalitis virus; the mainstay of therapy is supportive care.[3]
Historical Perspective
California encephalitis virus was first discovered in 1943 in Kern County, California. In 1945, the first human cases of encephalitis were attributed to this new virus. Three cases in total were reported, and all three cases were Kern County residents. In all three cases there was strong laboratory evidence confirming infection, due to the presence of neutralizing antibodies linked to California encephalitis.[4]
Classification
There is no classification system established for California encephalitis virus. California encephalitis virus belongs to the Group V negative-sense ssRNA virus within the Bunyaviridae family of viruses, and the genus Orthobunyavirus. California encephalitis virus is also known as an arbovirus, or an arthropod-borne virus.[1] The California encephalitis serogroup, which contains genetically similar viruses such as the La Crosse virus, shares its name with the virus.
Pathophysiology
California encephalitis virus is usually transmitted via mosquitos to the human host.[1] California encephalitis virus contains negative-sense viral RNA; this RNA is complementary to mRNA and thus must be converted to positive-sense RNA by an RNA polymerase before translation. California encephalitis virus is made up of an enveloped virion with a helically symmetrical capsid. The envelope contains G1 glycoproteins. Neutralizing antibodies against these proteins block fusion of the virus with host cells and inhibit hemagglutination. The virus genome is over 12000 nucleotides in length and consists of three segments of various sized single-stranded RNA (negative sense and ambi-sense).
California encephalitis virus is contracted by the bite of an infected mosquito, primarily Aedes triseriatus. The virus is maintained and amplified in Aedes triseriatus populations through transovarial and venereal transmission. The virus overwinters in the mosquito egg. Amplification also occurs in chipmunks and squirrels, upon which mosquitos feed. Humans are dead-end hosts for the virus, meaning there is an insufficient amount of California encephalitis virus in the blood stream to infect a mosquito. Subsequently, the disease cannot be spread to other humans. The incubation period is 5-15 days.[2]
Causes
California encephalitis virus causes encephalitis in humans.
Differentiating California Encephalitis Virus from other Diseases
California encephalitis virus must be differentiated from other diseases that cause fever, headache, seizures, and altered mental status, such as:[1][5][6][7][8]
Disease | Similarities | Differentials |
---|---|---|
Meningitis | Classic triad of fever, nuchal rigidity, and altered mental status | Photophobia, phonophobia, rash associated with meningococcemia, concomitant sinusitis or otitis, swelling of the fontanelle in infants (0-6 months) |
Brain abscess | Fever, headache, hemiparesis | Varies depending on the location of the abscess; clinically, visual disturbance including papilledema, decreased sensation; on imaging, a lesion demonstrates both ring enhancement and central restricted diffusion |
Demyelinating diseases | Ataxia, lethargy | Multiple sclerosis: clinically, nystagmus, internuclear ophthalmoplegia, Lhermitte's sign; on imaging, well-demarcated ovoid lesions with possible T1 hypointensities (“black holes”)
Acute disseminated encephalomyelitis: clinically, somnolence, myoclonic movements, and hemiparesis; on imaging, diffuse or multi-lesion enhancement, with indistinct lesion borders |
Substance abuse | Tremor, headache, altered mental status | Varies depending on type of substance: prior history, drug-seeking behavior, attention-seeking behavior, paranoia, sudden panic, anxiety, hallucinations |
Electrolyte disturbance | Fatigue, headache, nausea | Varies depending on deficient ions; clinically, edema, constipation, hallucinations; on EKG, abnormalities in T wave, P wave, QRS complex; possible presentations include arrhythmia, dehydration, renal failure |
Stroke | Ataxia, aphasia, dizziness | Varies depending on classification of stroke; presents with positional vertigo, high blood pressure, extremity weakness |
Intracranial hemorrhage | Headache, coma, dizziness | Lobar hemorrhage, numbness, tingling, hypertension, hemorrhagic diathesis |
Trauma | Headache, altered mental status | Amnesia, loss of consciousness, dizziness, concussion, contusion |
Epidemiology and Demographics
Incidence
There are approximately 70-115 cases of California encephalitis virus per year in the United States.
Age
California encephalitis virus commonly affects individuals between 6 months old and 15 years of age.
Seasonal
The majority of California encephalitis virus cases are reported in the summer months between July and September, and peaks in August.
Geographic Location
The majority of California encephalitis virus cases are reported in the Midwestern United States, especially those living in rural and suburban settings surrounded by deciduous forests.[9]
Risk Factors
Common risk factors in the development of California encephalitis virus include:
- Young age
- Residing or working in rural and suburban settings
- Mosquito contact
- Summer season
- Outdoor activities such as camping or hunting
Natural History, Complications, and Prognosis
Natural History
California encephalitis virus usually clears in 1 to 2 weeks and rarely recurs.
Complications
Common complications of California encephalitis virus include:
- Recurring seizures
- Coma
- Loss of basic motor skills
- Loss of coordination
Prognosis
Prognosis for California encephalitis virus is generally good, with most individuals returning to full health in 2-3 weeks. Less than 1% of cases result in mortality.[2] However, approximately 20% of patients have residual seizures.
Diagnosis
History and Symptoms
If possible, a detailed and thorough history from the patient is necessary. In rare cases, California encephalitis virus presents with symptoms mimicking herpes simplex encephalitis.[10] Common symptoms of California encephalitis virus include:[1][11]
Physical Examination
Common physical examination findings of California encephalitis virus include:[2]
- Fever
- Ataxia
- Seizures
- Somnolence
- Obtundation
- Myalgia
- Acute flaccid myelitis
- Acute flaccid paralysis
Laboratory Findings
The diagnostic method of choice for California encephalitis virus is laboratory testing. Laboratory findings consistent with the diagnosis of California encephalitis virus include:[2]
- Serologic cross-reactivity
- Presence of IgM antibodies
- Persistence of IgG and neutralizing antibodies
- Confirmation of arboviral-specific neutralizing antibodies in enzyme linked immunosorbent assay (ELISA)
EEG
On EEG, California encephalitis virus is characterized by periodic lateralizing epilepitoform discharges.[1] However, results on imaging are not sufficient evidence to warrant California encephalitis virus diagnosis.
Treatment
Medical Therapy
There is no treatment for California encephalitis virus; the mainstay of therapy is supportive care.[3]
Surgery
Surgical intervention is not recommended for the management of California encephalitis virus.[1]
Prevention
There are no available vaccines against California encephalitis virus. Primary prevention strategies include:[2]
- Removal of standing water
- Screens on doors and windows
- When outdoors, wearing:
- Insect repellent containing DEET
- Long sleeves, pants; tucking in pants into high socks
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.
- ↑ 3.0 3.1 The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America. http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Encephalitis.pdf Accessed on February 16, 2016.
- ↑ Eldridge BF, Glaser C, Pedrin RE, Chiles RE (2001). "The first reported case of California encephalitis in more than 50 years". Emerg Infect Dis. 7 (3): 451–2. doi:10.3201/eid0703.010316. PMC 2631795. PMID 11384526.
- ↑ Kennedy PG (2004). "Viral encephalitis: causes, differential diagnosis, and management". J Neurol Neurosurg Psychiatry. 75 Suppl 1: i10–5. PMC 1765650. PMID 14978145.
- ↑ Arboviral Infections (arthropod-borne encephalitis, eastern equine encephalitis, St. Louis encephalitis, California encephalitis, Powassan encephalitis, West Nile encephalitis). New York State Department of Health (2006). https://www.health.ny.gov/diseases/communicable/arboviral/fact_sheet.htm Accessed on February 23, 2016
- ↑ Eckstein C, Saidha S, Levy M (2012). "A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis". J Neurol. 259 (5): 801–16. doi:10.1007/s00415-011-6240-5. PMID 21932127.
- ↑ De Kruijk JR, Twijnstra A, Leffers P (2001). "Diagnostic criteria and differential diagnosis of mild traumatic brain injury". Brain Inj. 15 (2): 99–106. doi:10.1080/026990501458335. PMID 11260760.
- ↑ Goldman L, Schafer AI. Goldman's Cecil Medicine. Elsevier Health Sciences; 2011.
- ↑ Sokol DK, Kleiman MB, Garg BP (2001). "LaCrosse viral encephalitis mimics herpes simplex viral encephalitis". Pediatr Neurol. 25 (5): 413–5. PMID 11744319.
- ↑ Richie MB, Josephson SA (2015). "A Practical Approach to Meningitis and Encephalitis". Semin Neurol. 35 (6): 611–20. doi:10.1055/s-0035-1564686. PMID 26595861.
- ↑ "Public Health Image Library (PHIL)".